Metastatic Cancer

Recruitment is underway for a small study focused on the ability of psilocybin to reduce anxiety among individuals with metastatic cancer.

CHICAGO — Researchers were unable to identify a discrete genomic biomarker of PFS after second line of therapy to help guide first-line regimen selection for patients with advanced clear cell renal cell carcinoma, according to a poster presentation at ASCO Annual Meeting.

Aggressive end-of-life care remains common among older individuals with metastatic cancer despite increased efforts over the past several decades to reduce such interventions, according to study results published in JAMA Network Open.

High-intensity aerobic exercise may decrease the risk for cancer metastasis by 72%, according to a study conducted at Tel Aviv University.

Liquid biopsy effectively predicted survival outcomes among a cohort of patients with various metastatic cancer types, according to study results published in Annals of Oncology.

CHICAGO — Patients with high-deductible health plans experienced delays in detection of metastatic cancer, according to results of an observational study presented during ASCO Annual Meeting.

The American Cancer Society and Flatiron Health presented a grant to Dawn Hershman, MD, MS, FASCO, to support research into the use, toxicity and efficacy of oral antineoplastic drugs among Black and Hispanic patients.

A medical student said she looks forward to learning more about oncology and clinical practice after leading a retrospective study that showed racial and ethnic disparities in end-of-life care among patients with metastatic cancer.